First-in-human study with the inhaled TLR9 oligonucleotide agonist AZD1419 results in interferon responses in the lung, and is safe and well-tolerated
Jackson, Sam, Candia, Albert F., Delaney, Stephen, Floettmann, Simone, Wong, Clifford, Campbell, John D., Kell, Sariah, Lum, Jeremy, Hessel, Edith, Traquina, Paula, McHale, Mark, Robinson, Ian, Bell,Langue:
english
Journal:
Clinical Pharmacology & Therapeutics
DOI:
10.1002/cpt.938
Date:
November, 2017
Fichier:
PDF, 2.71 MB
english, 2017